Scarica l'app Stockscreener
13.85
0.43%
-0.06
Dopo l'orario di chiusura:
13.98
0.13
+0.94%
Precedente Chiudi:
$13.91
Aprire:
$14.13
Volume 24 ore:
38,022
Relative Volume:
0.77
Capitalizzazione di mercato:
$681.69M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+1.69%
1M Prestazione:
-9.71%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$13.36
$14.29
Intervallo di 1 settimana:
$13.20
$15.46
Portata 52W:
$13.20
$17.45
Agomab Therapeutics Nv Adr Stock (AGMB) Company Profile
Nome
Agomab Therapeutics Nv Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare AGMB vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AGMB
Agomab Therapeutics Nv Adr
|
13.85 | 681.69M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Agomab Therapeutics Nv Adr Stock (AGMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-03 | Iniziato | JP Morgan | Overweight |
| 2026-03-03 | Iniziato | Leerink Partners | Outperform |
| 2026-03-03 | Iniziato | Morgan Stanley | Overweight |
Agomab Therapeutics Nv Adr Borsa (AGMB) Ultime notizie
Total liabilities & shareholders' equities of AgomAb Therapeutics NV ADR – DUS:M5E - TradingView
Total debt of AgomAb Therapeutics NV ADR – DUS:M5E - TradingView
AgomAb Therapeutics NV ADR Balance Sheet – DUS:M5E - TradingView
EBITDA per share of AgomAb Therapeutics NV ADR – DUS:M5E - TradingView
AgomAb Therapeutics NV ADR Earnings and Revenue – DUS:M5E - TradingView
Basic earnings per share (basic EPS) of AgomAb Therapeutics NV ADR – DUS:M5E - TradingView
Free float of AgomAb Therapeutics NV ADR – DUS:M5E - TradingView
Total common shares outstanding of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Tangible book value per share of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Debt to assets ratio of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Cash per share of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Net current asset value per share of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Enterprise value to EBITDA ratio of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
EBITDA margin % of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
AgomAb Therapeutics NV ADR Cash Flow – TRADEGATE:M5E - TradingView
AgomAb Therapeutics NV ADR Balance Sheet – TRADEGATE:M5E - TradingView
EBITDA of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Diluted earnings per share (diluted EPS) of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Non-operating income (total) of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
AgomAb Therapeutics NV ADR Financial Statements – TRADEGATE:M5E - TradingView
Diluted net income available to common stockholders of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
AgomAb Therapeutics NV ADR Revenue Breakdown – TRADEGATE:M5E - TradingView
AgomAb Therapeutics NV ADR Statistics – TRADEGATE:M5E - TradingView
Gross profit of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Net income before discontinued operations of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Operating income of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Total revenue of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Non-controlling/minority interest of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
AgomAb Therapeutics NV ADR Income Statement – TRADEGATE:M5E - TradingView
AgomAb Therapeutics NV ADR Earnings and Revenue – TRADEGATE:M5E - TradingView
Free float of AgomAb Therapeutics NV ADR – TRADEGATE:M5E - TradingView
Agomab closes $200 million IPO on NASDAQ - Investing.com India
Agomab closes $200 million IPO on NASDAQ By Investing.com - Investing.com Nigeria
Agomab Announces Closing of Initial Public Offering - Benzinga
EQT Life Sciences-Backed AgomAb Falls After $200 Million IPO - Mint
Agomab Therapeutics opens below IPO price in Nasdaq debut By Investing.com - Investing.com Canada
Agomab Therapeutics opens below IPO price in Nasdaq debut - Investing.com
Agomab prices IPO at $16 per share, aims to raise $200 million - Investing.com Australia
Agomab prices IPO at $16 per share, aims to raise $200 million By Investing.com - Investing.com India
symbol__ Stock Quote Price and Forecast - CNN
Agomab Therapeutics Nv Adr Azioni (AGMB) Dati Finanziari
Non sono disponibili dati finanziari per Agomab Therapeutics Nv Adr (AGMB). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):